AlphaYouRR
Insider selling
Reshma Rangwala sold $4K of Karyopharm Therapeutics Inc. (KPTI) stock
Reshma Rangwala, EVP & Chief Medical Officer of Karyopharm Therapeutics Inc. (KPTI), sold 449 shares of KPTI stock worth $4K, per an SEC Form 4 filed Apr 22, 2026.
It was an open-market sale.
The trade happened on Apr 21, 2026, 1 day before it was made public.
KPTI has moved -79.7% since the trade date, from $9.17 to $1.86 (Sep 21, 2026 close).
- Traded
- Apr 21, 2026
- Disclosed
- Apr 22, 2026
- Filing delay
- 1 day
- Price since
- -79.7%
- Role
- EVP & Chief Medical Officer
- Source
- SEC Form 4
More KPTI insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.